Variant report
Variant | esv1008385 |
---|---|
Chromosome Location | chr11:104202033-104212143 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DDI1-3 | chr11:104209820-104209872 | XLOC_009266 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563594943 | chr11:104205084-104205085 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529541048 | chr11:104205086-104205087 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112806967 | chr11:104205105-104205106 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368115197 | chr11:104205230-104205231 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374009174 | chr11:104205277-104205278 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143023622 | chr11:104205280-104205281 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190206728 | chr11:104205288-104205289 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113317639 | chr11:104205293-104205294 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376602748 | chr11:104205358-104205359 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577247762 | chr11:104205367-104205368 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530891835 | chr11:104205379-104205380 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550995130 | chr11:104205390-104205391 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567707994 | chr11:104205420-104205421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112254164 | chr11:104205431-104205432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553338630 | chr11:104205460-104205461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186713994 | chr11:104205469-104205470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112233775 | chr11:104205590-104205591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558583074 | chr11:104205729-104205730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566868286 | chr11:104205735-104205736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575250321 | chr11:104205744-104205745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368520739 | chr11:104205784-104205785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149668132 | chr11:104207644-104207645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145446795 | chr11:104207730-104207731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561324508 | chr11:104207748-104207749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184006517 | chr11:104207760-104207761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565129053 | chr11:104207813-104207814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188296529 | chr11:104207940-104207941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537474259 | chr11:104207967-104207968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181049062 | chr11:104207987-104207988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148907521 | chr11:104208062-104208063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs80022596 | chr11:104208137-104208138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566658239 | chr11:104208193-104208194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547987152 | chr11:104208198-104208199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567958153 | chr11:104208242-104208243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115713021 | chr11:104208244-104208245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547501870 | chr11:104208249-104208250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1387204 | chr11:104208279-104208280 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs186035542 | chr11:104208323-104208324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558951195 | chr11:104208328-104208329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115007893 | chr11:104208377-104208378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538585866 | chr11:104208424-104208425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200395321 | chr11:104208436-104208437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555191906 | chr11:104208453-104208454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575121418 | chr11:104208454-104208455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373844317 | chr11:104208456-104208457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376495626 | chr11:104208466-104208467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11226307 | chr11:104208494-104208495 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs145311062 | chr11:104208508-104208509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559943822 | chr11:104208583-104208584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149101682 | chr11:104208586-104208587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104205000-104205400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr11:104205200-104205800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr11:104207600-104209400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr11:104207800-104209400 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr11:104208000-104208400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr11:104208000-104208800 | Enhancers | Aorta | Aorta |
7 | chr11:104208000-104209400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr11:104208000-104210000 | Enhancers | HMEC | breast |
9 | chr11:104208200-104208800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr11:104208200-104208800 | Enhancers | HSMMtube | muscle |
11 | chr11:104208200-104209400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr11:104208600-104209400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr11:104208600-104209800 | Enhancers | Dnd41 | blood |
14 | chr11:104208800-104209400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr11:104208800-104209400 | Enhancers | NHEK | skin |
16 | chr11:104209800-104210200 | Flanking Active TSS | Dnd41 | blood |
17 | chr11:104209800-104210600 | Enhancers | Fetal Thymus | thymus |
18 | chr11:104210000-104221800 | Weak transcription | HMEC | breast |
19 | chr11:104210200-104211800 | Enhancers | Dnd41 | blood |